Mangoceuticals (MGRX) Shares Outstanding (2022 - 2026)

Mangoceuticals has reported Shares Outstanding (Entity) for 5 years, with the latest figure at $17.0 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 269.41% year-over-year to $17.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $17.0 million (up 269.41% YoY) and the FY2025 annual result came in at $10.1 million, up 408.93% from the prior year.
• Shares Outstanding (Entity) improved to $17.0 million in Q1 2026 per MGRX's latest filing, from $10.1 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $17.0 million in Q1 2026 and troughed at $719908.0 in Q4 2022.
• A 5-year average of $4.5 million and a median of $2.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) surged 49.22% in 2023, then surged 439.87% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $719908.0 in 2022, then surged by 49.22% to $1.1 million in 2023, then soared by 84.22% to $2.0 million in 2024, then jumped by 408.93% to $10.1 million in 2025, then jumped by 68.47% to $17.0 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $17.0 million, $10.1 million, and $11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.